ezetimibe has been researched along with Brain Ischemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Catapano, AL; Cosin-Sales, J; Ezhov, MV; Farnier, M; Granados, D; Khan, I; Liu, J; Santoni, S; Santos, RD | 1 |
| Nussbaumerová, B | 1 |
| Abtan, J; Amarenco, P; Béjot, Y; Bruckert, E; Cabrejo, L; Cha, JK; Charles, H; Ducrocq, G; Giroud, M; Guidoux, C; Hobeanu, C; Kim, JS; Kim, YJ; Labreuche, J; Lapergue, B; Lavallée, PC; Lee, BC; Lee, KB; Leys, D; Mahagne, MH; Meseguer, E; Nighoghossian, N; Pico, F; Samson, Y; Sibon, I; Steg, PG; Sung, SM; Touboul, PJ; Touzé, E; Varenne, O; Vicaut, É; Yelles, N | 1 |
| Amarenco, P; Bruckert, E; Charles, H; Gabriel Steg, P; Giroud, M; Kim, JS; Labreuche, J; Lee, BC; Mahagne, MH; Nighoghossian, N; Vicaut, É | 1 |
| Alahmari, A; Almalki, ZS; Alotaibi, N; Guo, JJ; Thaibah, H | 1 |
| Elkind, MS; Yaghi, S | 1 |
| Acha-Salazar, O; Larrosa-Campo, D; Novo-Robledo, F; Oterino, A; Palacio, E; Revilla, M; Viadero-Cervera, R | 1 |
1 review(s) available for ezetimibe and Brain Ischemia
| Article | Year |
|---|---|
Lipids and Cerebrovascular Disease: Research and Practice.
Topics: Brain Ischemia; Cerebral Hemorrhage; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Ezetimibe; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Leukoencephalopathies; Lipoprotein(a); Practice Guidelines as Topic; Primary Prevention; Secondary Prevention; Stroke; Triglycerides | 2015 |
3 trial(s) available for ezetimibe and Brain Ischemia
| Article | Year |
|---|---|
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Topics: Adult; Aged; Anticholesteremic Agents; Atherosclerosis; Brain Ischemia; Cardiovascular Diseases; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intention to Treat Analysis; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Stroke | 2020 |
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke.
Topics: Aged; Anticholesteremic Agents; Brain Ischemia; Cholesterol, LDL; Drug Delivery Systems; Ezetimibe; Female; Humans; Male; Middle Aged; Stroke; Time Factors | 2020 |
Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.
Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Brain Ischemia; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Quality-Adjusted Life Years; Saudi Arabia; Simvastatin; Treatment Outcome | 2018 |
3 other study(ies) available for ezetimibe and Brain Ischemia
| Article | Year |
|---|---|
Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries.
Topics: Brain Ischemia; Cholesterol, LDL; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Stroke | 2022 |
Hypertension and dyslipidemia treament in stroke.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brain Ischemia; Calcium Channel Blockers; Cholesterol, LDL; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indapamide; Stroke | 2022 |
[Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack].
Topics: Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Retrospective Studies; Stroke | 2016 |